Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 529


Pulmonary and circulatory parameter guided anesthesia in patients with ischemic stroke undergoing endovascular recanalization.

Mundiyanapurath S, Stehr A, Wolf M, Kieser M, Möhlenbruch M, Bendszus M, Hacke W, Bösel J.

J Neurointerv Surg. 2015 Mar 16. pii: neurintsurg-2014-011523. doi: 10.1136/neurintsurg-2014-011523. [Epub ahead of print]


Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.

Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Devlin TG, Lopes DK, Reddy V, du Mesnil de Rochemont R, Jahan R; SWIFT PRIME Investigators.

Int J Stroke. 2015 Apr;10(3):439-48. doi: 10.1111/ijs.12459.


Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial.

Singer DE, Hellkamp AS, Yuan Z, Lokhnygina Y, Patel MR, Piccini JP, Hankey GJ, Breithardt G, Halperin JL, Becker RC, Hacke W, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Investigators.

J Am Heart Assoc. 2015 Mar 3;4(3). pii: e001349. doi: 10.1161/JAHA.114.001349.


Repeated Intra-Arterial Thrombectomy within 72 Hours in a Patient with a Clear Contraindication for Intravenous Thrombolysis.

Laible M, Möhlenbruch M, Hacke W, Bendszus M, Ringleb PA, Rizos T.

Case Rep Vasc Med. 2015;2015:872817. doi: 10.1155/2015/872817. Epub 2015 Jan 27.


Evidence-Based Guidelines for the Management of Large Hemispheric Infarction : A Statement for Health Care Professionals from the Neurocritical Care Society and the German Society for Neuro-Intensive Care and Emergency Medicine.

Torbey MT, Bösel J, Rhoney DH, Rincon F, Staykov D, Amar AP, Varelas PN, Jüttler E, Olson D, Huttner HB, Zweckberger K, Sheth KN, Dohmen C, Brambrink AM, Mayer SA, Zaidat OO, Hacke W, Schwab S.

Neurocrit Care. 2015 Jan 21. [Epub ahead of print]


Interventional thrombectomy for major stroke--a step in the right direction.

Hacke W.

N Engl J Med. 2015 Jan 1;372(1):76-7. doi: 10.1056/NEJMe1413346. Epub 2014 Dec 17. No abstract available.


Haemorrhage and hemicraniectomy: refining surgery for stroke.

Bösel J, Zweckberger K, Hacke W.

Curr Opin Neurol. 2015 Feb;28(1):16-22. doi: 10.1097/WCO.0000000000000167.


Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial.

Hacke W, Schellinger PD, Albers GW, Bornstein NM, Dahlof BL, Fulton R, Kasner SE, Shuaib A, Richieri SP, Dilly SG, Zivin J, Lees KR; NEST 3 Committees and Investigators.

Stroke. 2014 Nov;45(11):3187-93. doi: 10.1161/STROKEAHA.114.005795. Epub 2014 Oct 7.


Statins reduce peri-procedural complications in carotid stenting.

Reiff T, Amiri H, Rohde S, Hacke W, Ringleb PA.

Eur J Vasc Endovasc Surg. 2014 Dec;48(6):626-32. doi: 10.1016/j.ejvs.2014.08.010. Epub 2014 Sep 16.


Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.

Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, Becker RC, Singer DE, Halperin JL, Hacke W, Nessel CC, Berkowitz SD, Mahaffey KW, Fox KA, Califf RM, Piccini JP; ROCKET-AF Steering Committee and Investigators.

Eur Heart J. 2015 Feb 1;36(5):288-96. doi: 10.1093/eurheartj/ehu359. Epub 2014 Sep 10.


Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial.

Breithardt G, Baumgartner H, Berkowitz SD, Hellkamp AS, Piccini JP, Stevens SR, Lokhnygina Y, Patel MR, Halperin JL, Singer DE, Hankey GJ, Hacke W, Becker RC, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators.

Eur Heart J. 2014 Dec 14;35(47):3377-85. doi: 10.1093/eurheartj/ehu305. Epub 2014 Aug 22.


Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.

Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W; Stroke Thrombolysis Trialists' Collaborative Group.

Lancet. 2014 Nov 29;384(9958):1929-35. doi: 10.1016/S0140-6736(14)60584-5. Epub 2014 Aug 5. Review.


[Interdisciplinary neuromedicine].

Oertel W, Hacke W.

Nervenarzt. 2014 Aug;85(8):927. doi: 10.1007/s00115-014-4034-6. German. No abstract available.


Testing devices for the prevention and treatment of stroke and its complications.

Bath PM, Brainin M, Brown C, Campbell B, Davis SM, Donnan GA, Ford GA, Hacke W, Iglesias C, Lees KR, Pugh SS, Saver JL, Schellinger PD, Truelsen T.

Int J Stroke. 2014 Aug;9(6):683-95. doi: 10.1111/ijs.12302.


Hemicraniectomy for middle-cerebral-artery stroke. Author reply.

Jüttler E, Unterberg A, Hacke W.

N Engl J Med. 2014 Jun 12;370(24):2347-8. doi: 10.1056/NEJMc1404585. No abstract available.


Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators.

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.


Management of acute stroke in patients taking novel oral anticoagulants.

Hankey GJ, Norrving B, Hacke W, Steiner T.

Int J Stroke. 2014 Jul;9(5):627-32. doi: 10.1111/ijs.12295. Epub 2014 Jun 2. Review.


Time to treatment with recombinant tissue plasminogen activator and outcome of stroke in clinical practice: retrospective analysis of hospital quality assurance data with comparison with results from randomised clinical trials.

Gumbinger C, Reuter B, Stock C, Sauer T, Wiethölter H, Bruder I, Rode S, Kern R, Ringleb P, Hennerici MG, Hacke W; AG Schlaganfall.

BMJ. 2014 May 30;348:g3429. doi: 10.1136/bmj.g3429.


Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial.

Steinberg BA, Hellkamp AS, Lokhnygina Y, Halperin JL, Breithardt G, Passman R, Hankey GJ, Patel MR, Becker RC, Singer DE, Hacke W, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM, Piccini JP; ROCKET AF Steering Committee and Investigators.

Heart Rhythm. 2014 Jun;11(6):925-32. doi: 10.1016/j.hrthm.2014.03.006. Epub 2014 May 13.


[Professor Brandt retires as editor: characterized Der Nervenarzt over 25 years].

Hacke W, Maier W, Braun C.

Nervenarzt. 2014 Jun;85(6):667-8. doi: 10.1007/s00115-014-4071-1. German. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk